Neuralink, Elon Musk's brain implant company, receives FDA approval for human trials.

Elon Musk's brain-implant company, Neuralink, has received FDA approval to conduct the first clinical trial of its experimental device in humans. The device is surgically inserted into the brain by a robot and capable of decoding brain activity and linking it to computers. The company has raised at least $363 million and has more than 400 employees. Neuralink's brain chip technology has been designed to be sewn into the surface of the brain, and a robotic device performs the surgery. The company has even bigger ambitions: creating a device that not only restores human function but enhances it.